Market closed
Prices delayed by at least 15 minutes | Prices updated on 29 Apr 2025, 17.12 BST | Print
International Biotechnology Trust PLC (IBT)
ORD 25POpen
604.00p
Previous close
600.00p
Trade high
608.00p
Estimated NAV
668.256
Year high
736.00p
Year low
480.00p
Premium / Discount
-10.21%
Market capitalisation
£212.75 mn
Volume
18,016
Dividend yield
–
Ongoing charge
1.2698%
ISIN
GB0004559349
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Before investing please read:
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 26/07/2024 | 20/12/2024 |
| Ex-dividend date | 25/07/2024 | 19/12/2024 |
| Payment date | 23/08/2024 | 24/01/2025 |
| Amount | 14.50p | 15.56p |
Net asset value (NAV)
| Estimated NAV | 668.26 |
|---|---|
| Latest actual NAV | 654.29 |
| Latest actual NAV date | 25 April 2025 |
| 12m average premium/discount | -10.1% |
Top 10 holdings
| Holdings 31/03/2025 | % of assets |
|---|---|
| SpringWorks Therapeutics Inc Ordinary Shares | 8.87 |
| Ascendis Pharma AS ADR | 5.47 |
| Cytokinetics Inc | 4.65 |
| uniQure NV | 4.22 |
| Sv Fund Vi Investment | 3.98 |
| Sv Bcof | 3.97 |
| Biomarin Pharmaceutical Inc | 3.79 |
| Vera Therapeutics Inc Class A | 3.69 |
| Travere Therapeutics Inc Ordinary Shares | 3.56 |
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Morningstar ratingTM
Morningstar sustainability ratingTM
Benchmarks
Category
Sector Equity Biotechnology
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 29/04/2025 | 03:56:10 | 608 | 3 | 18.24 |
| 29/04/2025 | 03:52:03 | 599.5 | 2,426 | 14,543.87 |
| 29/04/2025 | 03:49:00 | 603 | 2,171 | 13,091.13 |
| 29/04/2025 | 03:49:00 | 603 | 2,157 | 13,006.71 |
| 29/04/2025 | 03:27:38 | 607.3999 | 1 | 6.07 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.